INTERFERON-Ƴ RELEASE ASSAY VERSUS TUBERCULIN SKIN TEST IN PATIENTS WITH MODERATE-TO-SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PURSUIT UC PROGRAM

(2) Immunology,Janssen R & D, LLC,Spring House,United States

(3) Biostatistics,Janssen R & D, LLC,Spring House,United States

(4) Gastroenterology,University of California San Diego,La Jolla,United States

(5) Gastroenterology,University of Hospital Gasthuisberg,Leuven,Belgium



This item was part of UEG Week 2015

This item can be cited as: United European Gastroenterology Journal; 2015: 2 (Supplement 1)